PET in neurotherapeutic discovery and development
Positron emission tomography (PET) is a highly sensitive, quantitative imaging technique that can track sub-nanomolar quantities of positron-emitting radionuclides throughout the body. By incorporating such radionuclides into molecules of interest, we can directly assess their pharmacokinetic and ph...
Saved in:
Main Authors: | Melissa Chassé, Neil Vasdev |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Neurotherapeutics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747924001855 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
[18F]FDG PET-Based Radiomics and Machine Learning for the Assessment of Gliomas and Glioblastomas: A Systematic Review
by: Francesco Dondi, et al.
Published: (2025-01-01) -
Research on the characteristics of 18F-FDG PET/CT in mantle cell lymphoma and the discrimination between cellular morphological variants
by: REN Yixuan, et al.
Published: (2024-12-01) -
The N-acetyltransferase 10 inhibitor [11C]remodelin: synthesis and preliminary positron emission tomography study in mice
by: Rui Luo, et al.
Published: (2025-01-01) -
An Analysis of Age-Related Body Composition Changes and Metabolic Patterns in Korean Adults Using FDG-PET/CT Health Screening Data
by: Chang-Myung Oh, et al.
Published: (2025-01-01) -
Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET
by: Yong-Jin Park, et al.
Published: (2025-01-01)